ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,473Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 29

$553K Total Retail Price of All Prescriptions

Rank: 13 out of 29

270 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 270 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 9,362 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 500 498 1 1
AMLODIPINE BESYLATE 368 367 2 5
OMEPRAZOLE 346 346 3 8
NAMENDA 296 296 4 12
DONEPEZIL HCL 282 282 5 9
METOPROLOL SUCCINATE 279 279 6 16
MIRTAZAPINE 249 249 7 13
PRAVASTATIN SODIUM 244 244 8 18
GABAPENTIN 233 224 9 10
HYDROCODONE-ACETAMINOPHEN 230 216 S3 10 7
ATORVASTATIN CALCIUM 220 220 11 25
FUROSEMIDE 205 195 12 3
SYNTHROID 201 201 13 52
SERTRALINE HCL 200 200 14 17
EVISTA 198 192 15 55
POTASSIUM CHLORIDE 194 194 16 6
CLONIDINE HCL 164 164 17 53
TRAMADOL HCL 132 132 18 24
LISINOPRIL 121 121 19 2
METOPROLOL TARTRATE 101 101 20 15
CLOPIDOGREL 100 100 21 33
TRIAMTERENE-HCTZ 98 98 22 48
EXELON 96 96 23 38
ATENOLOL 95 95 24 23
BUSPIRONE HCL 93 93 25 97
CRESTOR 93 82 25 62
MELOXICAM 92 87 27 36
CYMBALTA 92 92 27 29
FAMOTIDINE 88 84 29 61
QUETIAPINE FUMARATE 80 80 30 32
FENTANYL 71 71 S2 31 76
ZOLPIDEM TARTRATE 69 69 32 30
ESCITALOPRAM OXALATE 68 68 33 37
POLYETHYLENE GLYCOL 3350 68 68 33 46
AMLODIPINE BESYLATE-BENAZEPRIL 65 65 35 119
NEXIUM 64 64 36 47
PANTOPRAZOLE SODIUM 64 64 36 59
FLUTICASONE PROPIONATE 63 61 38 43
PLAVIX 59 59 39 51
HYDROCHLOROTHIAZIDE 55 55 40 20
BENAZEPRIL HCL 54 54 41 83
FLUOXETINE HCL 53 53 42 106
DIOVAN 51 51 43 35
LATANOPROST 50 50 44 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.